261 related articles for article (PubMed ID: 16151787)
1. [Lipid lowering drug and other toxic myopathies].
Schoser BG; Pongratz D
Internist (Berl); 2005 Nov; 46(11):1198-206. PubMed ID: 16151787
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced Myopathies.
Steinmeyer J; Flechtenmacher J
Z Orthop Unfall; 2023 Apr; 161(2):175-181. PubMed ID: 34320661
[TBL] [Abstract][Full Text] [Related]
3. Drug-related myopathies of which the clinician should be aware.
Valiyil R; Christopher-Stine L
Curr Rheumatol Rep; 2010 Jun; 12(3):213-20. PubMed ID: 20425521
[TBL] [Abstract][Full Text] [Related]
4. [Drug-induced and toxic myopathies].
Coquet M; Bannwarth B; Henin D
Rev Prat; 2001 Feb; 51(3):278-83. PubMed ID: 11265424
[TBL] [Abstract][Full Text] [Related]
5. Detecting Toxic Myopathies as Medication Side Effect.
Gerena-Maldonado E
Phys Med Rehabil Clin N Am; 2018 Nov; 29(4):659-667. PubMed ID: 30293621
[TBL] [Abstract][Full Text] [Related]
6. Lipid-lowering agents and myopathy.
Wortmann RL
Curr Opin Rheumatol; 2002 Nov; 14(6):643-7. PubMed ID: 12410084
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced myopathies.
Le Quintrec JS; Le Quintrec JL
Baillieres Clin Rheumatol; 1991 Apr; 5(1):21-38. PubMed ID: 2070426
[TBL] [Abstract][Full Text] [Related]
8. Toxic myopathies.
Pasnoor M; Barohn RJ; Dimachkie MM
Neurol Clin; 2014 Aug; 32(3):647-70, viii. PubMed ID: 25037083
[TBL] [Abstract][Full Text] [Related]
9. Myopathy and rhabdomyolysis with lipid-lowering drugs.
Hodel C
Toxicol Lett; 2002 Mar; 128(1-3):159-68. PubMed ID: 11869826
[TBL] [Abstract][Full Text] [Related]
10. Drugs causing muscle disease.
Mor A; Wortmann RL; Mitnick HJ; Pillinger MH
Rheum Dis Clin North Am; 2011 May; 37(2):219-31, vi. PubMed ID: 21444021
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced myopathies.
Bannwarth B
Expert Opin Drug Saf; 2002 May; 1(1):65-70. PubMed ID: 12904161
[TBL] [Abstract][Full Text] [Related]
12. [Indirect and mixed mechanisms of action in toxic myopathies].
Khelfi A; Azzouz M; Abtroun R; Reggabi M; Alamir B
Ann Pharm Fr; 2018 Jul; 76(4):273-285. PubMed ID: 29803327
[TBL] [Abstract][Full Text] [Related]
13. [Myopathies under therapy with lipid-lowering agents].
Köller H; Neuhaus O; Schroeter M; Hartung HP
Nervenarzt; 2005 Feb; 76(2):212-7. PubMed ID: 15609055
[TBL] [Abstract][Full Text] [Related]
14. Iatrogenic and toxic myopathies.
Sieb JP; Gillessen T
Muscle Nerve; 2003 Feb; 27(2):142-56. PubMed ID: 12548521
[TBL] [Abstract][Full Text] [Related]
15. MRI in lipid-lowering agent-associated myopathy: a retrospective review of 21 cases.
Peters SA; Kley R; Tegenthoff M; Vorgerd M; Nicolas V; Heyer CM
AJR Am J Roentgenol; 2010 Apr; 194(4):W323-8. PubMed ID: 20308477
[TBL] [Abstract][Full Text] [Related]
16. Myalgias and Myopathies: Drug-Induced Myalgias and Myopathies.
Holder K
FP Essent; 2016 Jan; 440():23-7. PubMed ID: 26734833
[TBL] [Abstract][Full Text] [Related]
17. [Medically induced myopathia].
Finsterer J
Nervenarzt; 2006 Jun; 77(6):682-6, 688-93. PubMed ID: 16575599
[TBL] [Abstract][Full Text] [Related]
18. Toxic and drug-induced myopathies.
Dalakas MC
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):832-8. PubMed ID: 19608783
[TBL] [Abstract][Full Text] [Related]
19. Toxic myopathies.
George KK; Pourmand R
Neurol Clin; 1997 Aug; 15(3):711-30. PubMed ID: 9227960
[TBL] [Abstract][Full Text] [Related]
20. Other Myopathies.
Hussain Y; Miller S
Neurol Clin; 2020 Aug; 38(3):619-635. PubMed ID: 32703473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
